Publication | Open Access
Bispecific Antibodies Enable Synthetic Agonistic Receptor-Transduced T Cells for Tumor Immunotherapy
43
Citations
42
References
2019
Year
We describe a novel ACT platform with antitumor activity in murine and human tumor models with a distinct mode of action that combines adoptive T-cell therapy with bispecific antibodies.
| Year | Citations | |
|---|---|---|
Page 1
Page 1